Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Generation of lentivirus vectors using recombinant baculoviruses.

Lesch HP, Turpeinen S, Niskanen EA, Mähönen AJ, Airenne KJ, Ylä-Herttuala S.

Gene Ther. 2008 Sep;15(18):1280-6. doi: 10.1038/gt.2008.76. Epub 2008 May 8.

PMID:
18463689
2.

Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase.

Usami Y, Popov S, Popova E, Göttlinger HG.

J Virol. 2008 May;82(10):4898-907. doi: 10.1128/JVI.02675-07. Epub 2008 Mar 5.

3.

NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains.

Chung HY, Morita E, von Schwedler U, Müller B, Kräusslich HG, Sundquist WI.

J Virol. 2008 May;82(10):4884-97. doi: 10.1128/JVI.02667-07. Epub 2008 Mar 5.

4.

Advances in FIV vaccine technology.

Uhl EW, Martin M, Coleman JK, Yamamoto JK.

Vet Immunol Immunopathol. 2008 May 15;123(1-2):65-80. doi: 10.1016/j.vetimm.2008.01.030. Epub 2008 Jan 20. Review.

5.

Molecular characterization of feline immunodeficiency virus budding.

Luttge BG, Shehu-Xhilaga M, Demirov DG, Adamson CS, Soheilian F, Nagashima K, Stephen AG, Fisher RJ, Freed EO.

J Virol. 2008 Mar;82(5):2106-19. Epub 2007 Dec 19.

6.

Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes.

Pistello M, Vannucci L, Ravani A, Bonci F, Chiuppesi F, del Santo B, Freer G, Bendinelli M.

Genet Vaccines Ther. 2007 Sep 19;5:8.

7.

The role of ubiquitin in retroviral egress.

Martin-Serrano J.

Traffic. 2007 Oct;8(10):1297-303. Epub 2007 Jul 20. Review.

8.

Biogenesis and function of multivesicular bodies.

Piper RC, Katzmann DJ.

Annu Rev Cell Dev Biol. 2007;23:519-47. Review.

9.

Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.

Segura MM, Garnier A, Durocher Y, Coelho H, Kamen A.

Biotechnol Bioeng. 2007 Nov 1;98(4):789-99.

PMID:
17461423
10.

Animal models used for the evaluation of antiretroviral therapies.

Dias AS, Bester MJ, Britz RF, Apostolides Z.

Curr HIV Res. 2006 Oct;4(4):431-46. Review.

PMID:
17073618
11.
12.
13.

Lessons from the cat: development of vaccines against lentiviruses.

Dunham SP.

Vet Immunol Immunopathol. 2006 Jul 15;112(1-2):67-77. Epub 2006 May 5. Review.

PMID:
16678276
14.

HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway.

Martin-Serrano J, Eastman SW, Chung W, Bieniasz PD.

J Cell Biol. 2005 Jan 3;168(1):89-101. Epub 2004 Dec 28.

15.

Retrovirus budding.

Demirov DG, Freed EO.

Virus Res. 2004 Dec;106(2):87-102. Review.

PMID:
15567490
16.

Functional domains in the feline immunodeficiency virus nucleocapsid protein.

Manrique ML, Rauddi ML, González SA, Affranchino JL.

Virology. 2004 Sep 15;327(1):83-92.

17.

Context-dependent effects of L domains and ubiquitination on viral budding.

Martin-Serrano J, Perez-Caballero D, Bieniasz PD.

J Virol. 2004 Jun;78(11):5554-63.

18.

Transmission and immunopathogenesis of FIV in cats as a model for HIV.

Burkhard MJ, Dean GA.

Curr HIV Res. 2003 Jan;1(1):15-29. Review.

PMID:
15043209
19.

Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases.

Power C, Zhang K, van Marle G.

J Neurovirol. 2004;10 Suppl 1:113-7. Review.

PMID:
14982749
20.

FIV: from lentivirus to lentivector.

Saenz DT, Poeschla EM.

J Gene Med. 2004 Feb;6 Suppl 1:S95-104. Review.

PMID:
14978754
Items per page

Supplemental Content

Write to the Help Desk